Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions by Ahmad, HA, East, JE, Panaccione, R, Travis, S, Canavan, JB, Usiskin, K, Byrne, MF

Artificial intelligence in inflammatory bowel disease endoscopy: implications for clinical trials by Ahmad, HA, East, JE, Panaccione, R, Travis, S, Canavan, JB, Usiskin, K, Byrne, MF

The 5C concept and 5S principles in Inflammatory Bowel Disease management. by Hibi, T, Panaccione, R, Katafuchi, M, Yokoyama, K, Watanabe, K, Matsui, T, Matsumoto, T, Travis, S, Suzuki, Y

Incorporating patient experience into drug development for ulcerative colitis: development of the Urgency Numeric Rating Scale, a patient-reported outcome measure to assess bowel u... by Dubinsky, MC, Irving, PM, Panaccione, R, Naegeli, AN, Potts-Bleakman, A, Arora, V, Shan, M, Travis, S

The Crohn's disease–ulcerative colitis clinical appraisal update: emerging trends in clinical practice by Sandborn, W, Colombel, J, D'Haens, G, Ghosh, S, Panaccione, R, Panés, J, Travis, S, Peyrin-Biroulet, L

The real-world global use of patient-reported outcomes for the care of patients with inflammatory bowel disease by Horrigan, JM, Louis, E, Spinelli, A, Travis, S, Moum, B, Salwen-Deremer, J, Halfvarson, J, Panaccione, R, Dubinsky, MC, Munkholm, P, Siegel, CA

Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn’s Disease in US and Europe: Results from the Cross-Sectional C... by Schreiber, S, Hunter Gibble, T, Panaccione, R, Rubin, DT, Travis, S, Hibi, T, Potts Bleakman, A, Panni, T, Favia, AD, Kayhan, C, Atkinson, C, Saxena, S, Dubinsky, MC

Impact of bowel urgency on quality of life and clinical outcomes in patients with ulcerative colitis by Dubinsky, MC, Panaccione, R, Lewis, JD, Sands, BE, Hibi, T, Lee, SD, Naegeli, AN, Shan, M, Green, LA, Morris, N, Arora, V, Bleakman, AP, Belin, R, Travis, S

Effect of adalimumab dose escalation on clinical, health-related quality of life, treatment satisfaction and work productivity outcomes among patients with ulcerative colitis in a... by Travis, S, Feagan, B, Peyrin-Biroulet, L, Panaccione, R, Danese, S, Lazar, A, Robinson, A, Thakkar, R, Pappalardo, B, Petersson, J, Bereswill, M, Chen, N, Skup, M

Effect of adalimumab on extraintestinal manifestations among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA by Travis, S, Feagan, B, Peyrin-Biroulet, L, Panaccione, R, Danese, S, Lazar, A, Robinson, A, Thakkar, R, Pappalardo, B, Petersson, J, Bereswill, M, Chen, N, Skup, M

Review article: defining remission in ulcerative colitis. by Travis, S, Higgins, P, Orchard, T, Van Der Woude, C, Panaccione, R, Bitton, A, O'Morain, C, Panés, J, Sturm, A, Reinisch, W, Kamm, M, D'Haens, G

Lymphoma risk and overall safety profile of Adalimumab in patients with Crohn's disease with up to 6 years of follow-up in the pyramid by D'Haens, G, Reinisch, W, Panaccione, R, Satsangi, J, Petersson, J, Petersson, J, Arikan, D, Perotti, E, Robinson, A, Kalabic, J, Alperovich, G, Thakkar, R, Loftus, E

Effect of adalimumab on clinical outcomes and health-related quality of life among patients with ulcerative colitis in a clinical practice setting: Results from inspirADA by Travis, S, Feagan, BG, Peyrin-Biroulet, L, Panaccione, R, Danese, S, Lazar, A, Robinson, AM, Petersson, J, Pappalardo, BL, Bereswill, M, Chen, N, Wang, S, Skup, M, Thakkar, RB, Chao, J

Effect of adalimumab on clinical outcomes and health-related quality of life among patients with ulcerative colitis in a clinical practice setting: Results From InspirADA. by Travis, S, Feagan, BG, Peyrin-Biroulet, L, Panaccione, R, Danese, S, Lazar, A, Robinson, AM, Petersson, J, Pappalardo, BL, Bereswill, M, Chen, N, Wang, S, Skup, M, Thakkar, RB, Chao, J

Biomarker correlation with endoscopic outcomes in patients with Crohn's disease: data from CALM by Reinisch, W, Panaccione, R, Bossuyt, P, Baert, F, Armuzzi, A, Travis, S, Danese, S, Sandborn, W, D'Haens, G, Berg, S, Maa, J, Petersson, J, Neimark, E, Robinson, A, Colombel, J

Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial by Panaccione, R, Colombel, J, Travis, S, Bossuyt, P, Baert, F, Vaňásek, T, Danalıoğlu, A, Novacek, G, Armuzzi, A, Reinisch, W, Johnson, S, Buessing, M, Neimark, E, Petersson, J, Lee, W, D'Haens, G

Physician perspectives on unresolved issues in the use of conventional therapy in Crohn's disease: results from an international survey and discussion programme. by Ferrante, M, Karmiris, K, Newnham, E, Siffledeen, J, Zelinkova, Z, van Assche, G, Lakatos, P, Panés, J, Sturm, A, Travis, S, van der Woude, C, Reinisch, W, Colombel, J, Panaccione, R

Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process. by Peyrin-Biroulet, L, Billioud, V, D'Haens, G, Panaccione, R, Feagan, B, Panés, J, Danese, S, Schreiber, S, Ogata, H, Hibi, T, Higgins, P, Beaugerie, L, Chowers, Y, Louis, E, Steinwurz, F, Reinisch, W, Rutgeerts, P, Colombel, J, Travis, S, Sandborn, W

Application of deep learning models to improve ulcerative colitis endoscopic disease activity scoring under multiple scoring systems by Byrne, MF, Panaccione, R, East, JE, Iacucci, M, Parsa, N, Kalapala, R, Reddy, DN, Rughwani, HR, Singh, AP, Berry, SK, Monsurate, R, Soudan, F, Laage, G, Cremonese, ED, St-Denis, L, Lemaître, P, Nikfal, S, Asselin, J, Henkel, ML, Travis, S

The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis by Travis, S, Feagan, B, Sandborn, W, D'Haens, G, Pola, S, McDonald, J, Rutgeerts, P, Munkholm, P, Mittmann, U, King, D, Wong, C, Zou, G, Donner, A, Shackleton, L, Gilgen, D, Nelson, S, Vandervoort, M, Fahmy, M, Loftus Jr., E, Panaccione, R, Assche, G, Vermeire, S, Levesque, B